JP2001523264A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001523264A5 JP2001523264A5 JP1998548048A JP54804898A JP2001523264A5 JP 2001523264 A5 JP2001523264 A5 JP 2001523264A5 JP 1998548048 A JP1998548048 A JP 1998548048A JP 54804898 A JP54804898 A JP 54804898A JP 2001523264 A5 JP2001523264 A5 JP 2001523264A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4561997P | 1997-05-05 | 1997-05-05 | |
| US60/045,619 | 1997-05-05 | ||
| PCT/US1998/003197 WO1998050060A1 (en) | 1997-05-05 | 1998-05-05 | Therapies for acute renal failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009211128A Division JP2009286802A (ja) | 1997-05-05 | 2009-09-11 | 急性腎不全の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001523264A JP2001523264A (ja) | 2001-11-20 |
| JP2001523264A5 true JP2001523264A5 (enExample) | 2005-12-02 |
| JP5033276B2 JP5033276B2 (ja) | 2012-09-26 |
Family
ID=21938961
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54804898A Expired - Fee Related JP5033276B2 (ja) | 1997-05-05 | 1998-05-05 | 急性腎不全の治療 |
| JP2009211128A Withdrawn JP2009286802A (ja) | 1997-05-05 | 2009-09-11 | 急性腎不全の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009211128A Withdrawn JP2009286802A (ja) | 1997-05-05 | 2009-09-11 | 急性腎不全の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100105621A1 (enExample) |
| EP (1) | EP0980252B1 (enExample) |
| JP (2) | JP5033276B2 (enExample) |
| AT (1) | ATE278414T1 (enExample) |
| AU (1) | AU743510B2 (enExample) |
| CA (1) | CA2289123A1 (enExample) |
| DE (1) | DE69826854T2 (enExample) |
| DK (1) | DK0980252T3 (enExample) |
| ES (1) | ES2226125T3 (enExample) |
| PT (1) | PT980252E (enExample) |
| WO (1) | WO1998050060A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7612046B2 (en) | 2000-01-31 | 2009-11-03 | Uwe Waldemar Rothenpieler | Method for treating kidney disorders |
| DK1255569T3 (da) * | 2000-01-31 | 2010-12-06 | Uwe Waldemar Rothenpieler | Pax2 til behandling af nyresygdomme |
| US7498352B2 (en) | 2001-06-26 | 2009-03-03 | Takeda Pharmaceutical Company Limited | TGF-β superfamily production/secretion promoter |
| JP2006516020A (ja) * | 2002-08-28 | 2006-06-15 | キュリス インコーポレイテッド | 慢性腎不全の治療におけるモルフォゲン及びａｃｅ阻害薬の共投与 |
| RU2282899C2 (ru) * | 2004-01-09 | 2006-08-27 | ГОУ ВПО Омская Государственная Медицинская Академия | Способ моделирования инфекции мочевой системы |
| US7598364B2 (en) * | 2005-11-14 | 2009-10-06 | Merial Limited | Plasmid encoding canine BMP-7 |
| JP5175729B2 (ja) | 2006-07-21 | 2013-04-03 | 中外製薬株式会社 | 腎疾患治療剤 |
| US8979797B2 (en) * | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| US8956829B2 (en) | 2013-01-25 | 2015-02-17 | Warsaw Orthopedic, Inc. | Human recombinant growth and differentiaton factor-5 (rhGDF-5) |
| US9359417B2 (en) | 2013-01-25 | 2016-06-07 | Warsaw Orthopedic, Inc. | Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5) |
| US9051389B2 (en) | 2013-01-25 | 2015-06-09 | Warsaw Orthopedic, Inc. | Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5) |
| US9169308B2 (en) | 2013-01-25 | 2015-10-27 | Warsaw Orthopedic, Inc. | Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies |
| US8945872B2 (en) | 2013-01-25 | 2015-02-03 | Warsaw Orthopedic, Inc. | Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein |
| US10349640B2 (en) | 2014-02-07 | 2019-07-16 | Toru Miyazaki | Preventive or therapeutic agent for kidney disease |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156741B (it) | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
| US4342828A (en) | 1979-07-20 | 1982-08-03 | Morinaga Milk Industry Co., Ltd. | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells |
| US4627839A (en) * | 1985-11-21 | 1986-12-09 | American Hospital Supply Corporation | Patient controlled analgesia conversion |
| IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Osteoinductive factors |
| US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
| US5011691A (en) * | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
| US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
| US5045452A (en) * | 1988-09-02 | 1991-09-03 | Brigham And Women's Hospital | Method for evaluating nephrotoxicity |
| EP0429570B1 (en) | 1989-03-28 | 1998-01-14 | Genetics Institute, Inc. | Osteoinductive compositions |
| ATE209251T1 (de) | 1990-05-16 | 2001-12-15 | Genetics Inst | Knochen- und knorpel-bildung hervorrufende proteine |
| JPH0426624A (ja) | 1990-05-18 | 1992-01-29 | Tsumura & Co | 慢性腎不全改善剤 |
| ATE146076T1 (de) | 1990-06-22 | 1996-12-15 | Du Pont | Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten |
| US5849686A (en) * | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
| US7056882B2 (en) * | 1991-03-11 | 2006-06-06 | Curis, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
| CA2104678C (en) * | 1991-03-11 | 2002-05-14 | Charles M. Cohen | Protein-induced morphogenesis |
| US6194376B1 (en) * | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
| JP3627985B2 (ja) | 1991-03-11 | 2005-03-09 | キュリス インコーポレイテッド | タンパク質により誘導される形態形成 |
| US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
| ES2149776T5 (es) * | 1991-08-30 | 2004-07-01 | Curis, Inc. | Modulacion, inducida por un morfogeno, de la respuesta inflamatoria. |
| ATE308336T1 (de) * | 1991-08-30 | 2005-11-15 | Curis Inc | Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten |
| JP3616089B2 (ja) | 1991-08-30 | 2005-02-02 | キュリス インコーポレイテッド | 形態形成誘導蛋白のスクリーニング方法 |
| US6120760A (en) * | 1992-02-12 | 2000-09-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | Growth/differentiation factors of the TGF-β family |
| JP3981405B2 (ja) | 1992-07-31 | 2007-09-26 | ストライカー・コーポレーション | 形態形成蛋白質溶解型複合体，及びその組成 |
| AU681594B2 (en) * | 1992-07-31 | 1997-09-04 | Stryker Corporation | Morphogen-induced nerve regeneration and repair |
| WO1994003075A2 (en) | 1992-07-31 | 1994-02-17 | Creative Biomolecules, Inc. | Morphogen-enriched dietary composition |
| EP0661987B1 (en) | 1992-09-16 | 1998-01-14 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
| JPH08503198A (ja) | 1992-11-03 | 1996-04-09 | クリエイティブ バイオモレキュルズ，インコーポレイテッド | Ｏｐ−３誘導形態形成 |
| AU682176B2 (en) | 1993-03-04 | 1997-09-25 | Stryker Corporation | Method and compositions for recombinant osteogenic protein production |
| US5631159A (en) | 1993-09-22 | 1997-05-20 | Creative Biomolecules, Inc. | Lipid-modified serum free media |
| US5585237A (en) | 1993-10-25 | 1996-12-17 | Creative Biomolecules, Inc. | Methods and compositions for high protein production from recombinant DNA |
| ATE225666T1 (de) * | 1993-11-15 | 2002-10-15 | Celtrix Pharma | Verwendung von igf-1 und igfbp-3 zur herstellung eines arzneimittels zur behandlung von einer nierenerkrankung |
| US5525621A (en) * | 1994-05-20 | 1996-06-11 | Cytos Pharmaceuticals Llc | Imidazole derivatives as protective agents in reperfusion injury and severe inflammatory responses |
| US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
| US6214796B1 (en) * | 1996-03-22 | 2001-04-10 | The General Hospital Corporation | Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| US5820589A (en) * | 1996-04-30 | 1998-10-13 | Medtronic, Inc. | Implantable non-invasive rate-adjustable pump |
| US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
| US5879908A (en) * | 1997-04-30 | 1999-03-09 | Smithkline Beecham Corporation | CRFG-1a, a target and marker for chronic renal failure |
| US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
-
1998
- 1998-05-05 DK DK98919715T patent/DK0980252T3/da active
- 1998-05-05 PT PT98919715T patent/PT980252E/pt unknown
- 1998-05-05 DE DE69826854T patent/DE69826854T2/de not_active Expired - Lifetime
- 1998-05-05 AT AT98919715T patent/ATE278414T1/de active
- 1998-05-05 EP EP98919715A patent/EP0980252B1/en not_active Expired - Lifetime
- 1998-05-05 AU AU72443/98A patent/AU743510B2/en not_active Ceased
- 1998-05-05 ES ES98919715T patent/ES2226125T3/es not_active Expired - Lifetime
- 1998-05-05 WO PCT/US1998/003197 patent/WO1998050060A1/en not_active Ceased
- 1998-05-05 JP JP54804898A patent/JP5033276B2/ja not_active Expired - Fee Related
- 1998-05-05 CA CA002289123A patent/CA2289123A1/en not_active Abandoned
-
2009
- 2009-08-11 US US12/583,013 patent/US20100105621A1/en not_active Abandoned
- 2009-09-11 JP JP2009211128A patent/JP2009286802A/ja not_active Withdrawn
-
2011
- 2011-04-04 US US13/079,161 patent/US8748378B2/en not_active Expired - Fee Related